Effectiveness of a broad-spectrum bivalent mRNA vaccine against SARS-CoV-2 variants in preclinical studies-Reference-Cited by-同舟云学术

Effectiveness of a broad-spectrum bivalent mRNA vaccine against SARS-CoV-2 variants in preclinical studies

Published:2024-02-29 Issue:1 Volume:13 Page:
ISSN:2222-1751
Container-title:Emerging Microbes & Infections
language:en
Short-container-title:Emerging Microbes & Infections

Author:

Lu Jing¹²³⁴,Tan Shudan¹²³⁴,Gu Hao⁴,Liu Kunpeng⁵⁶,Huang Wei⁴,Yu Zhaoli⁴,Lu Guoliang¹²³,Wu Zihan¹²³,Gao Xiaobo⁴,Zhao Jinghua¹²³⁴,Yao Zongting⁴,Yi Feng⁴,Yang Yantao⁴,Wang Hu⁴,Hu Xue⁴,Lu Mingqing⁵⁶,Li Wei¹²³,Zhou Hui⁴,Yu Hang⁴,Shan Chao⁵⁶⁷,Lin Jinzhong¹²³^ORCID

Affiliation:

1. State Key Laboratory of Genetic Engineering, School of Life Sciences, Zhongshan Hospital, Fudan University, Shanghai, People’s Republic of China

2. Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, People’s Republic of China

3. Center for mRNA Translational Research, Fudan University, Shanghai, People’s Republic of China

4. Shanghai RNACure Biopharma Co., Ltd, Shanghai, People’s Republic of China

5. State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, People’s Republic of China

6. University of the Chinese Academy of Sciences, Beijing, People’s Republic of China

7. Hubei Jiangxia Laboratory, Wuhan, People’s Republic of China

Funder

National Natural Science Foundation of China

Starry Night Science Fund at Shanghai Institute for Advanced Study of Zhejiang University

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/22221751.2024.2321994

Reference30 articles.

1. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

2. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

3. Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil

4. Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization

5. Detection of a SARS-CoV-2 variant of concern in South Africa